Harmony Biosciences Holdings HRMY
NASDAQ HRMY
$39.27 -0.02 (-0.05%)
As of: Sep 30, 2026 · 3:59 PM EDT

Harmony Biosciences Holdings (HRMY) Operating Expenses (2019 - 2026)

Updated

Harmony Biosciences Holdings (HRMY) posted Operating Expenses of $108.77 million for Q2 2026, down 4.7% from $114.16 million a year earlier and down 18.6% from the prior quarter.

Analysis

Harmony Biosciences Holdings (HRMY) Operating Expenses (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Harmony Biosciences Holdings was $493.34 million, up 28.7% year-over-year; for FY2025, it came in at $461.64 million, up 25.8% from FY2024.

  • Annual Operating Expenses has increased for five consecutive years, with a five-year compound annual growth rate of 32.0% (FY2020 to FY2025).
  • In prior years, Harmony Biosciences Holdings' Operating Expenses was $367.09 million in FY2024 (+36.6%), $268.76 million in FY2023 (+14.8%), $234.19 million in FY2022 (+44.2%) and $162.39 million in FY2021 (+41.2%).
  • The Q2 2026 figure stands as the lowest quarterly Operating Expenses since Q1 2025.
  • On a year-over-year basis, Operating Expenses increased in six of the last eight quarters, with growth averaging 23.0%.
  • The strongest year-over-year quarter for Operating Expenses in the past five years was Q2 2024, with growth of 91.5%; the weakest was Q3 2023, with a decline of 22.9%.
  • According to Business Quant data, Operating Expenses for the three prior quarters was $133.58 million (Q1 2026), $136.67 million (Q4 2025) and $114.32 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 10.12 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 10.56 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -9.70 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 2.09 Bn
10 Harmony Biosciences Holdings 2.28 Bn -473.07 Mn 198.08 Mn 108.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 108.77 Mn
Mar 31, 2026 133.58 Mn
Dec 31, 2025 136.67 Mn
Sep 30, 2025 114.32 Mn
Jun 30, 2025 114.16 Mn
Mar 31, 2025 96.49 Mn
Dec 31, 2024 91.13 Mn
Sep 30, 2024 81.55 Mn
Jun 30, 2024 119.31 Mn
Mar 31, 2024 75.10 Mn
Dec 31, 2023 85.06 Mn
Sep 30, 2023 63.46 Mn
Jun 30, 2023 62.31 Mn
Mar 31, 2023 57.92 Mn
Dec 31, 2022 53.81 Mn
Sep 30, 2022 82.35 Mn
Jun 30, 2022 54.99 Mn
Mar 31, 2022 43.04 Mn
Dec 31, 2021 44.77 Mn
Sep 30, 2021 45.08 Mn
API Access

Harmony Biosciences Holdings Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=HRMY&period=max&api_key=YOUR_API_KEY